O=C1CN(/N=C\c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C([O-])=N1.[Na+]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?